Close Menu

The Indian pharmaceutical sector "was once notorious for making cheap knockoffs of Western medicines" to sell in developing countries, says the New York Times, but now it is a manufacturing center of drugs to sell worldwide. "What I see happening now is manufacturing and even packaging and even formulation are moving to India," says Jim Worrell, the chief executive of Pharma Services Network.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.